摘要
The coronavirus disease 2019(COVID-19)pandemic has resulted in significant morbidity and mortality since its first case was discovered in December 2019.Since then,multiple countries have witnessed a healthcare system collapse due to the overwhelming demand for COVID-19 care.Drastic measures have been taken globally in order to curb the spread of the virus.However,those measures have led to the disruption of other aspects of healthcare,increasing the burden due to other medical conditions.We have also stepped back in achieving the ambitious goal set in place by World Health Organization to eliminate viral hepatitis as a public threat by 2030.Hepatitis B and C are chronic conditions with a significant worldwide burden,and COVID-19 has resulted in many hepatitis elimination programs slowing or stopping altogether.In this review,we elucidate the impact of the ongoing COVID-19 pandemic on the interventions targeted towards the elimination of hepatitis B virus and hepatitis C virus.Some of the salient features that we have covered in this review include hindrance to screening and diagnostic tests,neonatal vaccinations,the transmission dynamics affecting hepatitis B virus and hepatitis C virus,role of limited awareness,restrictions to treatment accessibility,and disparity in healthcare services.We have highlighted the major issues and provided recommendations in order to tackle those challenges.
